Company news

Spectral Medical Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Spectral Medical Inc. Announces Closing of First Tranche of $14.0 Million Convertible Note Private Placement, Conversion of US$4.5 Million of Maturing Convertible Notes and Repayment of US$4.5 Million of Maturing Convertible Notes

November 2, 2026

Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA

September 11, 2026

Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update

August 7, 2026

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

June 25, 2026

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

June 9, 2026

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial

June 4, 2026

Spectral Medical Announces PMA Submission to U.S. FDA for PMX

May 29, 2026

Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update

May 8, 2026

Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference

April 1, 2026

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

March 26, 2026

Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine

March 24, 2026

Spectral Medical Provides Update on PMA Submission Timing for PMX-20R

February 26, 2026

Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update

November 7, 2025

Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF

September 29, 2025

Spectral Medical Announces Publication of EDEN Observational Study

September 16, 2025

Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025

September 8, 2025

Spectral Medical Receives US$3 Million From Vantive

August 25, 2025

Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

August 12, 2025

Spectral Medical Announces Second Quarter and Provides Corporate Update

August 8, 2025

Spectral Medical Inc. Announces Filing of Base Shelf Prospectus

July 4, 2025

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

June 6, 2025

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

May 16, 2025

Spectral Medical Announces First Quarter and Provides Corporate Update

May 9, 2025

Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive

May 7, 2025

Spectral Medical Completes Tigris Trial Enrollment

April 16, 2025

Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update

March 27, 2025

Spectral Medical Provides February Tigris Trial Update

March 3, 2025

Sidoti Events, LLC's Virtual November Micro-Cap Conference

November 14, 2023

Spectral Medical To Present At Microcap Rodeo's Annual Winter Wonderland- Best Ideas Virtual Investor Conference Today

February 22, 2023

Spectral to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

May 13, 2022

Spectral to Present at Investor Summit Group's Q2 In-person Conference on May 3rd in NYC

April 27, 2022

Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

December 6, 2021

Spectral to Present at the Q4 Investor Summit on November 16th

November 15, 2021

Spectral Medical to Present at the Q2 Virtual Investor Summit on May 17th

May 11, 2021

Keynotes, Educational Panels and 42 Canadian-Listed Public Companies to Present at the SNN Network Canada Virtual Event on January 6-7, 2021

January 5, 2021

Spectral Medical Inc. Opens the Market

September 18, 2019

Daily Coverage on Healthcare Stocks: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq Technologies

June 19, 2017

Research Reports Initiated on Healthcare Stocks Spectral Medical, GeneNews, Novadaq Technologies, and ProMIS Neurosciences

March 30, 2017

Research Reports Initiated on Healthcare Stocks GeneNews, Spectral Medical, ProMIS Neurosciences, and Novadaq Technologies

February 8, 2017

Spectral to Exhibit at the Critical Care Canada Forum

October 29, 2014

Spectral announces board changes

September 24, 2014

Spectral Announces Second Quarter, 2014 Results

August 13, 2014

Spectral Diagnostics and Toray Industries announce closing of Tranche "A" component of its up to $18.2 million Offering

July 25, 2014

Spectral Diagnostics announces shareholder approval of its up to $18.2 million offering

July 22, 2014

Spectral Announces ISS and Glass Lewis Recommendations to Vote in Favour of its up to $18.2 Million Offering

July 8, 2014

Spectral Diagnostics announces Proposed Offering of up to $18.2 million

June 11, 2014

U.S. FDA Approves Spectral's Amended Protocol for its EUPHRATES Trial

June 3, 2014

Spectral announces first quarter, 2014 results

May 15, 2014

Spectral Diagnostics provides update on results of annual and special meeting of shareholders

May 6, 2014

Spectral Diagnostics Announces Leading Independent Proxy Firms Recommend Spectral Shareholders Vote For Name Change and For Amendment of Warrants

April 21, 2014

Older news releases →

Calls

Decks